The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...

New York State’s stockpile of antiviral medications for flu contains only one drug, Tamiflu, leaving no fallback plan. By Joseph Goldstein A big boost for the military, more aid for Ukraine, a ...

The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.

The Trump administration on Wednesday canceled a $766 million contract with Moderna that funded efforts to develop a vaccine ...

Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza ...

VANCOUVER, BC, Nov. 5, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and ...

The funding boost Moderna Inc. had expected via a roughly $590 million Biomedical Advanced Research and Development Authority award now looks to be off the table. The company disclosed May 28 that the ...

Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...

Morningstar brands and products Company Portfolio ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...